๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Eltrombopag olamine - Medicines in Ireland

26 authorised products containing Eltrombopag olamine, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 26 authorised medicines
MedicineActive substanceLicence holderStatus
Eltrombopag Accord 12.5 mg film-coated tablets
EU/1/24/1903/001-004
Eltrombopag olamine Accord Healthcare S.L.U. โ€”
Eltrombopag Accord 25 mg film-coated tablets
EU/1/24/1903/005-010
Eltrombopag olamine Accord Healthcare S.L.U. โ€”
Eltrombopag Accord 50 mg film-coated tablets
EU/1/24/1903/011-016
Eltrombopag olamine Accord Healthcare S.L.U. โ€”
Eltrombopag Accord 75 mg film-coated tablets
EU/1/24/1903/017-022
Eltrombopag olamine Accord Healthcare S.L.U. โ€”
Eltrombopag Clonmel 25 mg film-coated tablets
PA0126/377/001
Eltrombopag olamine Clonmel Healthcare Ltd Marketed
Eltrombopag Clonmel 50 mg film-coated tablets
PA0126/377/002
Eltrombopag olamine Clonmel Healthcare Ltd Marketed
Eltrombopag Clonmel 75 mg film-coated tablets
PA0126/377/003
Eltrombopag olamine Clonmel Healthcare Ltd Not marketed
Eltrombopag MSN 25 mg film-coated tablets
PA23250/011/001
Eltrombopag olamine MSN Labs Europe Limited Not marketed
Eltrombopag MSN 50 mg film-coated tablets
PA23250/011/002
Eltrombopag olamine MSN Labs Europe Limited Not marketed
Eltrombopag Rowex 12.5 mg film-coated tablets
PA0711/345/001
Eltrombopag olamine Rowex Limited, Not marketed
Eltrombopag Rowex 25 mg film-coated tablets
PA0711/345/002
Eltrombopag olamine Rowex Limited, Not marketed
Eltrombopag Rowex 50 mg film-coated tablets
PA0711/345/003
Eltrombopag olamine Rowex Limited, Not marketed
Eltrombopag Rowex 75 mg film-coated tablets
PA0711/345/004
Eltrombopag olamine Rowex Limited, Not marketed
Eltrombopag Teva 25 mg Film-coated Tablets
PA22579/003/001
Eltrombopag olamine TEVA GmbH Marketed
Eltrombopag Teva 50 mg Film-coated Tablets
PA22579/003/002
Eltrombopag olamine TEVA GmbH Not marketed
Eltrombopag Viatris 12.5 mg film-coated tablets
EU/1/24/1869/001-004
Eltrombopag olamine Viatris Limited โ€”
Eltrombopag Viatris 25 mg film-coated tablets
EU/1/24/1869/005-008
Eltrombopag olamine Viatris Limited โ€”
Eltrombopag Viatris 50 mg film-coated tablets
EU/1/24/1869/009-012
Eltrombopag olamine Viatris Limited โ€”
Eltrombopag Viatris 75 mg film-coated tablets
EU/1/24/1869/013-016
Eltrombopag olamine Viatris Limited โ€”
Mylatabi 25 mg film-coated tablets
PA25239/004/001
Eltrombopag olamine Tillomed Malta Limited Not marketed
Mylatabi 50 mg film-coated tablets
PA25239/004/002
Eltrombopag olamine Tillomed Malta Limited Not marketed
Mylatabi 75 mg film-coated tablets
PA25239/004/003
Eltrombopag olamine Tillomed Malta Limited Not marketed
Revolade 12.5 mg film-coated tablets
EU/1/10/612/010-012
Eltrombopag olamine Novartis Europharm Limited โ€”
Revolade 25 mg film-coated tablets
EU/1/10/612/1-3
Eltrombopag olamine Novartis Europharm Limited โ€”
Revolade 25 mg powder for oral suspension
EU/1/10/612/013
Eltrombopag olamine Novartis Europharm Limited โ€”
Revolade 50 mg film-coated tablets
EU/1/10/612/4-6
Eltrombopag olamine Novartis Europharm Limited โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 15 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.